Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction
- PMID: 33136513
- PMCID: PMC7805557
- DOI: 10.1161/CIRCULATIONAHA.119.041818
Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction
Abstract
There is a lack of consensus on how we define heart failure with preserved ejection fraction (HFpEF), with wide variation in diagnostic criteria across society guidelines. This lack of uniformity in disease definition stems in part from an incomplete understanding of disease pathobiology, phenotypic heterogeneity, and natural history. We review current knowledge gaps and existing diagnostic tools and algorithms. We present a simple approach to implement these tools within the constraints of the current knowledge base, addressing separately (1) hospitalized individuals with rest congestion, where diagnosis is more straightforward; and (2) individuals with exercise intolerance, where diagnosis is more complex. Here, a potential role for advanced or provocative testing, including evaluation of hemodynamic responses to exercise is considered. More importantly, we propose focus areas for future studies to develop accurate and feasible diagnostic tools for HFpEF, including animal models that recapitulate human HFpEF, and human studies that both address a fundamental understanding of HFpEF pathobiology, and new diagnostic approaches and tools, as well. In sum, there is an urgent need to more accurately define the syndrome of HFpEF to inform diagnosis, patient selection for clinical trials, and, ultimately, future therapeutic approaches.
Keywords: diagnosis; exercise test; heart failure.
Figures


Similar articles
-
Differential Clinical Profiles, Exercise Responses, and Outcomes Associated With Existing HFpEF Definitions.Circulation. 2019 Jul 30;140(5):353-365. doi: 10.1161/CIRCULATIONAHA.118.039136. Epub 2019 May 28. Circulation. 2019. PMID: 31132875 Free PMC article.
-
Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fraction.Int J Cardiol. 2013 Sep 30;168(2):716-22. doi: 10.1016/j.ijcard.2013.05.006. Epub 2013 May 24. Int J Cardiol. 2013. PMID: 23711448 Clinical Trial.
-
Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review.Heart Fail Rev. 2015 Nov;20(6):643-53. doi: 10.1007/s10741-015-9506-7. Heart Fail Rev. 2015. PMID: 26404098 Review.
-
[Heart failure with preserved ejection fraction (HFpEF)].Ther Umsch. 2018 Sep;75(3):161-169. doi: 10.1024/0040-5930/a000983. Ther Umsch. 2018. PMID: 30145974 Review. German.
-
Causes of exercise intolerance in heart failure with preserved ejection fraction: searching for consensus.J Card Fail. 2014 Oct;20(10):762-778. doi: 10.1016/j.cardfail.2014.07.010. Epub 2014 Aug 7. J Card Fail. 2014. PMID: 25108084 Review.
Cited by
-
Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscape.Heart Fail Rev. 2024 May;29(3):631-662. doi: 10.1007/s10741-024-10385-y. Epub 2024 Feb 27. Heart Fail Rev. 2024. PMID: 38411769 Free PMC article. Review.
-
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions.Cardiovasc Res. 2023 Feb 3;118(18):3403-3415. doi: 10.1093/cvr/cvac179. Cardiovasc Res. 2023. PMID: 36448685 Free PMC article. Review.
-
Automated Echocardiographic Detection of Heart Failure With Preserved Ejection Fraction Using Artificial Intelligence.JACC Adv. 2023 Jul 28;2(6):100452. doi: 10.1016/j.jacadv.2023.100452. eCollection 2023 Aug. JACC Adv. 2023. PMID: 38939447 Free PMC article.
-
Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction.Rev Cardiovasc Med. 2024 Jul 23;25(7):270. doi: 10.31083/j.rcm2507270. eCollection 2024 Jul. Rev Cardiovasc Med. 2024. PMID: 39139408 Free PMC article. Review.
-
Characteristics of patients with heart failure with preserved ejection fraction in primary care: a cross-sectional analysis.BJGP Open. 2021 Dec 14;5(6):BJGPO.2021.0094. doi: 10.3399/BJGPO.2021.0094. Print 2021. BJGP Open. 2021. PMID: 34465577 Free PMC article.
References
-
- Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–327. - PubMed
-
- Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WHW, Teerlink JR, Walsh MN. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16:e1–194. - PubMed
-
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, Van Der Meer P, Members AF. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical